Merck is ending a Phase 3 trial of Winrevair early so all PAH patients in HYPERION can start active treatment with the drug ...

A new study has highlighted the potential of resveratrol, a natural compound found in grapes, blueberries, and raspberries, to enhance female fertility. The systematic review found that resveratrol ...

Yes! I want to get the latest chemistry news from C&EN in my inbox every week. ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly ...

With that acquisition, they got this drug called Winrevair. It is approved by the FDA, just this last year for an almost always fatal disease called pulmonary arterial hypertension.” Cramer ...

The analyst lowered expectations for Januvia, Bridion, and ex-US Winrevair, while increasing projections for ... obesity treatment market by in-licensing a preclinical oral small molecule, GLP-1RA ...

The dosing regimen for Winrevair (sotatercept-csrk) is optimal for balancing efficacy and safety in adults with pulmonary arterial hypertension (PAH), an analysis of clinical trial data shows. This ...

Merck’s new 21-valent pneumococcal conjugate vaccine, Capvaxive, and pulmonary arterial hypertension drug, Winrevair, have the potential to generate significant revenues for Merck over the long ...

Bengaluru: Keros Therapeutics said on Wednesday it would voluntarily halt testing of an experimental blood pressure treatment due to safety concerns during a mid-stage trial, causing its shares to ...

Alboslani detailed this research in her presentation "X-ray echoes from Sgr A* reveal the 3D structure of molecular clouds in the Galactic Center" at the 245th meeting of the American Astronomical ...

The researchers from the Institute of Organic Chemistry were able to determine the 3D structure of SAMURI using X-ray crystallography and in collaboration with Professor Hermann Schindelin from ...